Healthcare Market Research Reports
| PRODUCT TITLE | PUBLISHED | |
|---|---|---|
 |
Stem cell therapy Stem cell therapy and Direct Nerve Repair, Nerve Grafting and... |
Upcoming |
|
|
Tags (RFID) Tags (RFID) and Readers (RFID) and Antenna (RFID) adds up to total... |
Upcoming |
|
|
Readers (RFID) Readers (RFID) and Tags (RFID) and Antenna (RFID) adds up to total Hardware... |
Upcoming |
|
|
Kaustubh-Payment Link-custom Antenna (RFID) and Tags (RFID) and Readers (RFID) adds up to total Hardware... |
Upcoming |
|
|
Active (Pharma Asset) Active (Pharma Asset) and Passive (Pharma Asset) adds up to total Tags (Pharma Asset) market. Active (Pharma Asset) can be segmented by Companies,... |
Upcoming |
|
|
Passive (Pharma Asset) Passive (Pharma Asset) and Active (Pharma Asset) adds up to total Tags (Pharma Asset) market. Passive (Pharma Asset) can be segmented by Companies,... |
Upcoming |
|
|
UHPLC Systems UHPLC Systems market has been pegged at $350.3m in the year 2013 growing at 6.3% annually and is projected to reach $474.8m by the end of the year 2018. UHPLC Systems constitute 10.1% of Global Liquid Chromatography Systems market and are poised to grow its... |
Upcoming |
|
|
UFLC Systems UFLC Systems market has been pegged at $101.5m in the year 2013 growing at 4.4% annually and is projected to reach $125.7m by the end of the year 2018. UFLC Systems constitute 2.9% of Global Liquid Chromatography Systems market and are poised to grow its... |
Upcoming |
|
|
Flash Chromatography Systems Flash Chromatography Systems market has been pegged at $243.9m in the year 2013 growing at 6.0% annually and is projected to reach $326.3m by the end of the year 2018. Flash Chromatography Systems constitute 7.0% of Global Liquid Chromatography Systems market... |
Upcoming |
|
|
Integrated CDSS Integrated CDSS and Standalone CDSS adds up to total Clinical Decision Support Systems market. Integrated CDSS can be segmented by Geographies, Components,... |
Upcoming |
|
|
Standalone CDSS Standalone CDSS and Integrated CDSS adds up to total Clinical Decision Support Systems market. Standalone CDSS can be segmented by Geographies, Components,... |
Upcoming |
|
|
Non-Knowledge based Clinical decision support systems (CDSS) The global non-knowledge based clinical decision support systems (CDSS) market was estimated at $23.0 million in 2012, and is expected to reach $26.0 million by 2018, at a CAGR of 1.6%.The non-knowledge based CDSS market is segmented into geography, application, technology, product, and end-user. Deep dive analysis of key players of this market have also been considered in this report. |
Upcoming |
|
|
Knowledge-based/Evidence based Clinical decision support systems (CDSS) The Global Knowledge-based Clinical decision support systems (CDSS) Market was valued at $245 million in 2012, and is expected to reach $418 million by 2018, at a CAGR of 9.6%. Knowledge-based CDSS market can be segmented by geography, application, technology, product, and end-user. Deep dive analysis of key players of this market have also been considered in this report. |
Upcoming |
|
|
Magnesium compounds Magnesium compounds and its peer markets - Clinical Trial Management Systems (CTMS), |
Upcoming |
|
|
Aluminium compounds Aluminium compounds and its peer markets - Chromatography Instruments, |
Upcoming |
|
|
Calcium compounds Calcium compounds and its peer markets - Healthcare IT outsourcing, |
Upcoming |
|
|
Combinations and complexes of aluminium, calcium and magnesium compounds Combinations and complexes of aluminium, calcium and magnesium compounds and its peer markets - Antacids with antiflatulents, |
Upcoming |
|
|
Antacids with antiflatulents Antacids with antiflatulents and its peer markets - Healthcare IT outsourcing, |
Upcoming |
|
|
H2-receptor antagonists H2-receptor antagonists and its peer markets - Chromatography, |
Upcoming |
|
|
Prostaglandins Prostaglandins and its peer markets - H2-receptor antagonists, |
Upcoming |
Healthcare
